Cargando…

Improved Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pacemaker Cells Using Novel Differentiation Protocols

Current protocols for the differentiation of human-induced pluripotent stem cells (hiPSC) into cardiomyocytes only generate a small amount of cardiac pacemaker cells. In previous work, we reported the generation of high amounts of cardiac pacemaker cells by co-culturing hiPSC with mouse visceral end...

Descripción completa

Detalles Bibliográficos
Autores principales: Darche, Fabrice F., Ullrich, Nina D., Huang, Ziqiang, Koenen, Michael, Rivinius, Rasmus, Frey, Norbert, Schweizer, Patrick A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266442/
https://www.ncbi.nlm.nih.gov/pubmed/35806319
http://dx.doi.org/10.3390/ijms23137318
_version_ 1784743475041796096
author Darche, Fabrice F.
Ullrich, Nina D.
Huang, Ziqiang
Koenen, Michael
Rivinius, Rasmus
Frey, Norbert
Schweizer, Patrick A.
author_facet Darche, Fabrice F.
Ullrich, Nina D.
Huang, Ziqiang
Koenen, Michael
Rivinius, Rasmus
Frey, Norbert
Schweizer, Patrick A.
author_sort Darche, Fabrice F.
collection PubMed
description Current protocols for the differentiation of human-induced pluripotent stem cells (hiPSC) into cardiomyocytes only generate a small amount of cardiac pacemaker cells. In previous work, we reported the generation of high amounts of cardiac pacemaker cells by co-culturing hiPSC with mouse visceral endoderm-like (END2) cells. However, potential medical applications of cardiac pacemaker cells generated according to this protocol, comprise an incalculable xenogeneic risk. We thus aimed to establish novel protocols maintaining the differentiation efficiency of the END2 cell-based protocol, yet eliminating the use of END2 cells. Three protocols were based on the activation and inhibition of the Wingless/Integrated (Wnt) signaling pathway, supplemented either with retinoic acid and the Wnt activator CHIR99021 (protocol B) or with the NODAL inhibitor SB431542 (protocol C) or with a combination of all three components (protocol D). An additional fourth protocol (protocol E) was used, which was originally developed by the manufacturer STEMCELL Technologies for the differentiation of hiPSC or hESC into atrial cardiomyocytes. All protocols (B, C, D, E) were compared to the END2 cell-based protocol A, serving as reference, in terms of their ability to differentiate hiPSC into cardiac pacemaker cells. Our analysis revealed that protocol E induced upregulation of 12 out of 15 cardiac pacemaker-specific genes. For comparison, reference protocol A upregulated 11, while protocols B, C and D upregulated 9, 10 and 8 cardiac pacemaker-specific genes, respectively. Cells differentiated according to protocol E displayed intense fluorescence signals of cardiac pacemaker-specific markers and showed excellent rate responsiveness to adrenergic and cholinergic stimulation. In conclusion, we characterized four novel and END2 cell-independent protocols for the differentiation of hiPSC into cardiac pacemaker cells, of which protocol E was the most efficient.
format Online
Article
Text
id pubmed-9266442
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92664422022-07-09 Improved Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pacemaker Cells Using Novel Differentiation Protocols Darche, Fabrice F. Ullrich, Nina D. Huang, Ziqiang Koenen, Michael Rivinius, Rasmus Frey, Norbert Schweizer, Patrick A. Int J Mol Sci Article Current protocols for the differentiation of human-induced pluripotent stem cells (hiPSC) into cardiomyocytes only generate a small amount of cardiac pacemaker cells. In previous work, we reported the generation of high amounts of cardiac pacemaker cells by co-culturing hiPSC with mouse visceral endoderm-like (END2) cells. However, potential medical applications of cardiac pacemaker cells generated according to this protocol, comprise an incalculable xenogeneic risk. We thus aimed to establish novel protocols maintaining the differentiation efficiency of the END2 cell-based protocol, yet eliminating the use of END2 cells. Three protocols were based on the activation and inhibition of the Wingless/Integrated (Wnt) signaling pathway, supplemented either with retinoic acid and the Wnt activator CHIR99021 (protocol B) or with the NODAL inhibitor SB431542 (protocol C) or with a combination of all three components (protocol D). An additional fourth protocol (protocol E) was used, which was originally developed by the manufacturer STEMCELL Technologies for the differentiation of hiPSC or hESC into atrial cardiomyocytes. All protocols (B, C, D, E) were compared to the END2 cell-based protocol A, serving as reference, in terms of their ability to differentiate hiPSC into cardiac pacemaker cells. Our analysis revealed that protocol E induced upregulation of 12 out of 15 cardiac pacemaker-specific genes. For comparison, reference protocol A upregulated 11, while protocols B, C and D upregulated 9, 10 and 8 cardiac pacemaker-specific genes, respectively. Cells differentiated according to protocol E displayed intense fluorescence signals of cardiac pacemaker-specific markers and showed excellent rate responsiveness to adrenergic and cholinergic stimulation. In conclusion, we characterized four novel and END2 cell-independent protocols for the differentiation of hiPSC into cardiac pacemaker cells, of which protocol E was the most efficient. MDPI 2022-06-30 /pmc/articles/PMC9266442/ /pubmed/35806319 http://dx.doi.org/10.3390/ijms23137318 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Darche, Fabrice F.
Ullrich, Nina D.
Huang, Ziqiang
Koenen, Michael
Rivinius, Rasmus
Frey, Norbert
Schweizer, Patrick A.
Improved Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pacemaker Cells Using Novel Differentiation Protocols
title Improved Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pacemaker Cells Using Novel Differentiation Protocols
title_full Improved Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pacemaker Cells Using Novel Differentiation Protocols
title_fullStr Improved Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pacemaker Cells Using Novel Differentiation Protocols
title_full_unstemmed Improved Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pacemaker Cells Using Novel Differentiation Protocols
title_short Improved Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pacemaker Cells Using Novel Differentiation Protocols
title_sort improved generation of human induced pluripotent stem cell-derived cardiac pacemaker cells using novel differentiation protocols
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266442/
https://www.ncbi.nlm.nih.gov/pubmed/35806319
http://dx.doi.org/10.3390/ijms23137318
work_keys_str_mv AT darchefabricef improvedgenerationofhumaninducedpluripotentstemcellderivedcardiacpacemakercellsusingnoveldifferentiationprotocols
AT ullrichninad improvedgenerationofhumaninducedpluripotentstemcellderivedcardiacpacemakercellsusingnoveldifferentiationprotocols
AT huangziqiang improvedgenerationofhumaninducedpluripotentstemcellderivedcardiacpacemakercellsusingnoveldifferentiationprotocols
AT koenenmichael improvedgenerationofhumaninducedpluripotentstemcellderivedcardiacpacemakercellsusingnoveldifferentiationprotocols
AT riviniusrasmus improvedgenerationofhumaninducedpluripotentstemcellderivedcardiacpacemakercellsusingnoveldifferentiationprotocols
AT freynorbert improvedgenerationofhumaninducedpluripotentstemcellderivedcardiacpacemakercellsusingnoveldifferentiationprotocols
AT schweizerpatricka improvedgenerationofhumaninducedpluripotentstemcellderivedcardiacpacemakercellsusingnoveldifferentiationprotocols